SecBot SecBot
SC 13G/A ·Filed Nov 12, 2026

AZTR

Azitra, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed5d 5h ago SEC0001493152-26-051273
Passive stake amendment
Actionable Insight • Neutral

No material change in ownership or intent. Monitor for any conversion of warrants into common shares, which would increase dilution but is capped by the 9.99% blocker.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$0.6685
T+0 close · Nov 12, 2026 · via day close
Latest settled
−8.99%
T+1 · $0.6084
Vs SPY
−8.63%
α at T+1
Next horizon
T+5
tomorrow
  1. T+0 · Nov 12 $0.6685entry
  2. T+1 · 4d ago −8.99%α −8.63% · $0.6084
  3. T+3 · todayOpen
  4. T+5 · tomorrow Pending
  5. T+20 · in 24d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Ayrton Capital LLC filed an amended Schedule 13G disclosing a 2.22% beneficial ownership stake in Azitra, Inc., consisting of 1,344,308 shares of common stock issuable upon exercise of warrants. The stake is unchanged from the prior filing, and the filing reaffirms passive intent.

Key Financial Metrics

Stake
2.22%
Investor
Ayrton Capital LLC
Investor Type
hedge fund

Key Facts

  • Ayrton Capital LLC reports 1,344,308 shares (2.22%) of Azitra common stock, all via warrants exercisable subject to a 9.99% blocker
  • Stake unchanged from prior SC 13G filing (June 2026)
  • Reporting persons include Ayrton Capital LLC, Alto Opportunity Master Fund SPC, and Waqas Khatri
  • Filing reaffirms passive investment intent under Rule 13d-1(b)

Financial Impact

No change in reported stake; warrants represent potential dilution of up to 2.22% of shares outstanding

dilution

Risk Factors

  • Warrant exercise could increase share count and dilute existing holders, though subject to blocker
  • No indication of activist intent; passive filing limits near-term catalyst

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001493152-26-051273
Document: 0001493152-26-051273-index.html0001493152-26-051273
Document: 0001493152-26-051273.txt0001493152-26-051273

Track record

16 reports on AZTR

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +38.73% at T+60 after the May 21, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13D Neutral 5/10 Entry $0.5805 Now $0.6090 +4.91% settles Feb 16
  2. Nov 12, 20264d ago Press Release Neutral 4/10 Entry $0.6084 Now $0.6090 +0.10% settles Feb 11
  3. Nov 12, 20264d ago 8-K Neutral 4/10 No price data
  4. Nov 12, 20265d ago SC 13G/A Neutral 2/10 Viewing Entry $0.6685 Now $0.6090 −8.90% settles Feb 10
  5. Nov 10, 20267d ago 8-K Neutral 3/10 Entry $0.6000 Now $0.6090 +1.50% settles Feb 8
  6. Nov 10, 20267d ago Press Release Neutral 3/10 Entry $0.6000 Now $0.6090 +1.50% settles Feb 8
  7. Oct 29, 202619d ago 8-K Neutral 3/10 Entry $0.7571 Now $0.6090 −19.56% settles Jan 27
  8. Oct 26, 202622d ago 8-K Neutral 4/10 Entry $1.53 Now $0.6090 −60.20% settles Jan 22
  9. Oct 22, 202626d ago 8-K Neutral 3/10 Entry $0.0715 Now $0.6090 +751.75% settles Jan 21
  10. Oct 1, 20266w ago 8-K Neutral 4/10 Entry $0.1285 Now $0.6090 +373.93% settles Dec 28
Showing 10 of 16

US Market Status

Market Closed · Opens Wed (17h 28m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026